Literature DB >> 23094728

Aspirin--from prevention to targeted therapy.

Boris Pasche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23094728     DOI： 10.1056/NEJMe1210322

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Role of inflammation and inflammatory mediators in colorectal cancer.

Authors:  Raymond N Dubois
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

Review 2.  Prevention and treatment of cancer with aspirin: where do we stand?

Authors:  Boris Pasche; Minghui Wang; Michael Pennison; Hugo Jimenez
Journal:  Semin Oncol       Date:  2014-04-24       Impact factor: 4.929

Review 3.  Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.

Authors:  Paul Lochhead; Andrew T Chan; Reiko Nishihara; Charles S Fuchs; Andrew H Beck; Edward Giovannucci; Shuji Ogino
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

Review 4.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Authors:  S Ogino; P Lochhead; E Giovannucci; J A Meyerhardt; C S Fuchs; A T Chan
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

5.  AMP-activated protein kinase regulates cancer cell growth and metabolism via nuclear and mitochondria events.

Authors:  Shanshan Jiang; Yan Wang; Lingyu Luo; Fuli Shi; Junrong Zou; Hui Lin; Ying Ying; Yunfei Luo; Zhan Zhan; Peijun Liu; Bo Zhu; Deqiang Huang; Zhijun Luo
Journal:  J Cell Mol Med       Date:  2019-04-16       Impact factor: 5.310

6.  A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1.

Authors:  Yichao Yan; Zhanlong Shen; Yingjiang Ye; Kewei Jiang; Hui Zhang; Chao Shen; Harri Mustonen; Pauli Puolakkainen; Shan Wang
Journal:  Med Oncol       Date:  2013-12-24       Impact factor: 3.064

Review 7.  Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Authors:  Shuji Ogino; Paul Lochhead; Andrew T Chan; Reiko Nishihara; Eunyoung Cho; Brian M Wolpin; Jeffrey A Meyerhardt; Alexander Meissner; Eva S Schernhammer; Charles S Fuchs; Edward Giovannucci
Journal:  Mod Pathol       Date:  2013-01-11       Impact factor: 7.842

8.  Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.

Authors:  Tao Yin; Guoping Wang; Tinghong Ye; Yongsheng Wang
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.